Solubilized delivery of paliperidone palmitate by d-alpha-tocopheryl polyethylene glycol 1000 succinate micelles for improved short-term psychotic management

References

• Alam MI, Bega S, Samad A, et al. (2010). Strategy for effective brain drug delivery. Eur J Pharm Sci 40:385–403
   PubMed Web of Science ®Google Scholar
• Béduneaua A, Saulnier P, Benoit JP. (2007). Active targeting of brain tumors using nanocarriers. Biomaterials 28:4947–67
   PubMed Web of Science ®Google Scholar
• Bharali DJ, Mousa SA. (2010). Emerging nanomedicines for early cancer detection and improved treatment: current perspective and future promise. Pharmacol Ther 128:324–35
   PubMed Web of Science ®Google Scholar
• Blanco E, Kessinger CW, Sumer BD, Gao J. (2009). Multifunctional micellar nanomedicine for cancer therapy. Exp Biol Med 234:123–31
   PubMed Web of Science ®Google Scholar
• Gan CW, Feng SS. (2010). Transferrin-conjugated nanoparticles of Poly (lactide) - d-α-tocopheryl polyethylene glycol succinate diblock copolymer for targeted drug delivery across the blood brain barrier. Biomaterials 31:7748–57
   PubMed Web of Science ®Google Scholar
• Gao Y, Li LB, Zhai G. (2008). Preparation and characterization of Pluronic/TPGS mixed micelles for solubilization of camptothecin. Coll Surf B: Biointerf 64:194–9
   PubMed Web of Science ®Google Scholar
• Guo Y, Luo J, Tan S, et al. (2013). The applications of Vitamin E TPGS in drug delivery. Eur J Pharm Sci 49:175–86
   PubMed Web of Science ®Google Scholar
• Hoy SM, Scott LJ, Keating GM. (2010). Intramuscular paliperidone palmitate. CNS Drugs 24:227–44
   PubMed Web of Science ®Google Scholar
• Jalali N, Moztarzadeh F, Mozafari M, et al. (2011). Surface modification of poly (lactide-co-glycolide) nanoparticles by d-α-tocopheryl polyethylene glycol 1000 succinate as potential carrier for the delivery of drugs to the brain. Coll Surf A: Physicochem Eng Aspects 392:335–42
   Web of Science ®Google Scholar
• Kabanov AV, Chekhonln VP, Alakhov VY, et al. (1989). The neuroleptic activity of haloperidol increases after its solubilization in surfactant micelles: micelles as microcontainers for drug targeting. FEBS Lett 258:343–5
   PubMed Web of Science ®Google Scholar
• Kim S, Shi Y, Kim JY, et al. (2010). Overcoming the barriers in micellar drug delivery: loading efficiency, in vivo stability, and micelle–cell interaction. Expert Opin Drug Deliv 7:49–62
   PubMed Web of Science ®Google Scholar
• Kreuter J. (2001). Nanoparticulate systems for brain delivery of drugs. Adv Drug Deliv Rev 47:65–81
   PubMed Web of Science ®Google Scholar
• Kulkarni SA, Feng SS. (2011). Effects of surface modification on delivery efficiency of biodegradable nanoparticles across the blood–brain barrier. Nanomedicine (Lond) 6:377–94
   PubMed Web of Science ®Google Scholar
• Mi Y, Liu Y, Feng SS. (2011). Formulation of docetaxel by folic acid-conjugated D-a-tocopheryl polyethylene glycol succinate 2000 (Vitamin E TPGS2k) micelles for targeted and synergistic chemotherapy. Biomaterials 32:4058–66
   PubMed Web of Science ®Google Scholar
• Mi Y, Zhao J, Feng SS. (2012). Vitamin E TPGS prodrug micelles for hydrophilic drug delivery with neuroprotective effects. Int J Pharm 438:98–106
   PubMed Web of Science ®Google Scholar
• Mu L, Feng SS. (2002). Vitamin E TPGS used as emulsifier in the solvent evaporation / extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (Taxol). J Control Rel 80:129–44
   PubMed Web of Science ®Google Scholar
• Muthu MS, Feng SS. (2009). Pharmaceutical stability aspects of nanomedicines. Nanomedicine (Lond) 4:857–60
   PubMed Web of Science ®Google Scholar
• Muthu MS, Feng SS. (2010). Nanopharmacology of liposomes developed for cancer therapy. Nanomedicine (Lond) 5:1017–19
   PubMed Web of Science ®Google Scholar
• Muthu MS. Leong DT, Mei L, Feng SS. (2014). Nanothernaostics: Application and further development of nanomedicine strategies for advanced theranostics. Theranostics 4: 660–77
   PubMed Web of Science ®Google Scholar
• Muthu MS, Kulkarni SA, Xiong J, Feng SS. (2011). Vitamin E TPGS coated liposomes enhanced cellular uptake and cytotoxicity of docetaxel in brain cancer cells. Int J Pharm 421:332–40
   PubMed Web of Science ®Google Scholar
• Muthu MS, Kulkarni SA, Liu Y, Feng SS. (2012a). Development of docetaxel-loaded vitamin E TPGS micelles: formulation optimization, effects on brain cancer cells and biodistribution in rats. Nanomedicine (Lond) 7:353–64
   PubMed Web of Science ®Google Scholar
• Muthu MS, Kulkarni SA, Raju A, Feng SS. (2012b). Theranostic liposomes of TPGS coating for targeted co-delivery of docetaxel and quantum dots. Biomaterials 33:3494–501
   PubMed Web of Science ®Google Scholar
• Muthu MS, Rajesh CV, Mishra A, Singh S. (2009a). Stimulus responsive targeted nanomicelles for effective cancer therapy. Nanomedicine (Lond) 4:657–67
   PubMed Web of Science ®Google Scholar
• Muthu MS, Rawat MK, Mishra A, Singh S. (2009b). PLGA nanoparticle formulations of risperidone: preparation and neuropharmacological evaluation. Nanomedicine 5:323–33
   PubMed Web of Science ®Google Scholar
• Muthu MS, Singh S. (2008). Studies on biodegradable polymeric nanoparticles of risperidone: in vitro and in vivo evaluation. Nanomedicine (Lond) 3:305–19
   PubMed Web of Science ®Google Scholar
• Muthu MS, Singh S. (2009). Targeted nanomedicines: effective treatment modalities for cancer, AIDS and brain disorders. Nanomedicine (Lond) 4:105–18
   PubMed Web of Science ®Google Scholar
• Muthu MS, Wilson B. (2010). Multifunctional radionanomedicine: a novel platform for effective cancer imaging and therapy. Nanomedicine (Lond) 5:169–71
   PubMed Web of Science ®Google Scholar
• Nussbaum AM, Stroup TS. (2012). Paliperidone palmitate for schizophrenia. Cochrane Database Syst Rev 6:CD008296
   PubMed Web of Science ®Google Scholar
• Paul DR, Robeson LM. (2008). Polymer nanotechnology: nanocomposites. Polymer 49:3187–204
   Web of Science ®Google Scholar
• Protais P, Costentin J, Schwartz JC. (1976). Climbing behaviour induced by apomorphine in mice: a simple test for the study of dopamine receptors in striatum. Psychopharmacology 50:1–6
   PubMed Web of Science ®Google Scholar
• Repka MA, McGinity JW. (2000). Influence of Vitamin E TPGS on the properties of hydrophilic films produced by hot-melt extrusion. Int J Pharm 202:63–70
   PubMed Web of Science ®Google Scholar
• Sahoo SK, Labhasetwar V. (2003). Nanotech approaches to drug delivery and imaging. Drug Discov Today 8:1112–20
   PubMed Web of Science ®Google Scholar
• Wilson B, Samanta MK, Santhi K, et al. (2008). Poly(n- butylcyanoacrylate) nanoparticles coated with polysorbate80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer's disease. Brain Res 1200:159–68
   PubMed Web of Science ®Google Scholar
• Zhang Z, Lee SH, Feng SS. (2007). Folate-decorated poly(lactide-co-glycolide)- vitamin E TPGS nanoparticles for targeted drug delivery. Biomaterials 28:1889–99
   PubMed Web of Science ®Google Scholar
• Zhang Z, Tan S, Feng SS. (2012). Vitamin E TPGS as a molecular biomaterial for drug delivery. Biomaterials 33:4889–906
   PubMed Web of Science ®Google Scholar